Reimagining therapeutic delivery
By creating innovative smart pills designed for targeted drug delivery to the GI tract and systemic, needle-free delivery of biotherapeutics, we are developing therapies to improve patients’ lives.
About Biora Therapeutics
Our Purpose
To develop innovative smart-pill technologies that improve patients’ lives.
Our Mission
At Biora, we are on a mission to reimagine therapeutics and their delivery.
Our Vision
We envision a world where all patients have access to needle-free drug delivery and better therapeutic outcomes.
Our History
The company was founded in 2010 as Ascendant MDx, Inc., and in 2013 changed its name to Progenity, Inc. In 2021, the company underwent a strategic transformation to focus on its innovative therapeutics pipeline, and in 2022 became Biora Therapeutics, Inc.
Biora Therapeutics is focused on developing therapeutics technologies that improve patients’ lives, through a revolutionary combination of drug therapies and smart capsule technology.